Jonathan Montagu
About Jonathan Montagu
Jonathan Montagu is a chemist and business executive who co-founded and serves as CEO, with a background in securing major pharmaceutical deals and contributing to drug development discourse.
Jonathan Montagu Professional Title
Jonathan Montagu is the Co-Founder and Chief Executive Officer. His leadership role highlights his significant responsibility in driving strategic direction and growth for the company.
Jonathan Montagu Education and Training
Jonathan Montagu trained as a chemist at several prestigious institutions such as Oxford University, Cold Spring Harbor Laboratory, The Scripps Research Institute, and Cancer Research UK. Additionally, he earned an MBA from Stanford Graduate School of Business, equipping him with comprehensive business acumen to complement his scientific expertise.
Jonathan Montagu Industry Experience
Jonathan Montagu has extensive experience in the pharmaceutical industry. He served as Chief Business Officer at Nimbus Therapeutics and as Vice President, Business Development at Concert Pharmaceuticals. His role in securing a notable $1B multi-product transaction with GSK underscores his capability in business development and strategic partnerships.
Jonathan Montagu Advisory and Directorial Roles
Jonathan Montagu is currently an Advisor at Atlas Venture, providing strategic guidance for venture investments. He also serves as a Non-Executive Director at OMass Therapeutics, where he contributes to governance, strategy, and organizational oversight.
Jonathan Montagu Published Works
Jonathan Montagu authored a blog post titled 'Signaling Complexes: A Ripe Opportunity for Drug Development.' The post reflects his insights into drug development, emphasizing opportunities in targeting signaling complexes for therapeutic interventions.